1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
(
- Contribution to journal › Article
- 2008
-
Mark
High-resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors.
(
- Contribution to journal › Article
- 2007
-
Mark
Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors
(
- Contribution to journal › Article